Abstract
The aim of the study was to evaluate the anatomic suitability for endovascular abdominal aneurysm repair (EVAR) according to instructions for use (IFUs) of three commercially available bifurcated stent graft devices and explore the possible benefits of low-profile delivery systems. Computed tomography scans of 241 patients with abdominal aortic aneurysm (AAA) were evaluated for suitability of Zenith Flex®, Gore Excluder® and Endurant® bifurcated stent graft systems according to their IFUs. The most common exclusion criteria and possible benefits of smaller diameter delivery systems were analyzed. When choosing the most suitable graft model for each patient, the overall suitability was 49.4%. By brand, the suitability was 28.6% for Zenith®, 25.7% for Gore Excluder® and 48.1% for Endurant®. By step wise accepting iliac diameters of ≥6 mm, ≥5 mm and ≥4 mm the overall suitability increased to 56.7, 58.9 and 60.2%, respectively (P < 0.001). Diameters below 4 mm had no additional effect on suitability as combinations of other anatomical features, with or without narrow iliacs, accounted for the remaining excluding factors. In conclusion, Less than half of patients with AAAs are suitable for EVAR according to current IFUs. Low-profile delivery systems may allow for endovascular treatment in up to 60% of patients.
Keywords
Introduction
Since the first report of successful endovascular aneurysm repair (EVAR) in 1991, 1 EVAR has become the first-line of treatment in most specialized centers. Evidence suggests that liberal use outside the instruction for use (IFU) definitions is common, compromising the long-term durability of the repair. 2 Previous reports have shown variable anatomical suitability for EVAR but few are based on the most conservative definitions making comparison difficult between patient cohorts. During the past years, endograft technology has been constantly improving with each new generation of devices being superior to their precursors allowing more patients to be treated. In hope of improving suitability further, a number of EVAR devices with low-profile delivery systems are now being tested in the clinical arena and awaiting regulatory approval. The aim of this study was to assess the current suitability of three widely used infrarenal EVAR devices and explore the possible benefits of low-profile delivery systems on suitability in an unselected cohort of patients with abdominal aneurysms.
Methods
All patients diagnosed with abdominal aortic aneurysms (AAA) at our clinic in 2006 and 2007 were prospectively enrolled in a computerized database. Evaluation of EVAR suitability was analyzed retrospectively in all patients where preoperative computed tomography (CT) scans were available. CT scans were performed on a 16- or 64-slice multidetector spiral CT scanner (Siemens, Erlanger, Germany) and reconstructed with 0.75–5 mm axial slices.
Anatomical requirements for EVAR according to IFUs
OD, outer diameter; ID, inner diameter; EVAR, endovascular aneurysm repair; IFU, instruction for use
Note that wide necks require wider iliac artery lumen for delivery of the bifurcated component
Statistics
One-way analysis of variance was used for analysis of length, diameter and angulation measurements. Chi-square test was used for gender and suitability comparisons in relation to iliac artery diameter. All statistical analysis was done in SPSS version 17.0 (SPSS Inc, Chicago, IL, USA,
Results
Aneurysm morphology and morphological differences between genders
*Non-significant differences
Most common exclusion criteria in the patient cohort
There were 55 different combinations of exclusion criteria for Zenith®, 53 for Excluder® and 28 for Endurant®
Current differences in suitability between different stent grafts and when reducing the acceptable diameter of the iliac arteries step wise
OD, outer diameter of delivery system
The relative increase from current suitability is given in parentheses
Discussion
Randomized trials have shown EVAR to be a valid treatment option in patients with AAAs. This minimally invasive approach offers patients a treatment with less morbidity and mortality than conventional open aneurysm surgery.3–5 The access route is most commonly through the iliac arteries where the delivery of stent grafts through tortuous, calcified or narrow vessels can lead to endothelial damage, dissection or arterial rupture. Significant access related complications occur in 5–17% of cases and poor access is reported as the most common exclusion criteria for EVAR and the leading cause of conversion into open repair. 6 When used on-label and in adherence to the manufacturers IFUs, currently approved and commercially available devices seem to perform remarkably well but unsatisfactory outcomes continue to occur. It was recently demonstrated that approximately half of patients have been treated outside the approved indications, resulting in aneurysm expansion during follow-up with risk of aneurysm rupture occurring later in life. 2
During the past few years, the field of endovascular treatment has rapidly expanded with substantial technological improvements, allowing for treatment of more complex aneurysms. Shorter, wider and more angulated necks are accepted and the delivery systems are hydrophilic and more flexible. 7 Despite this, a number of unmet needs are unresolved and have appropriately become the primary drivers for ongoing development. Among those are low-profile delivery systems, which are meant to obviate access issues and improve deliverability, as well as to facilitate and strengthen the evolving shift to percutaneous EVAR. In addition to the Endurant® device, which has an 18-F delivery system for necks up to 22 mm in diameter, a number of devices are waiting US approval with delivery systems between 14F and 18F in outer diameter (Ovation®, TriVascular, Inc, Santa Rosa, CA, USA; Incraft®, Cordis Corporation, Bridgewater, NJ, USA; Fortevo®, Aptus Endosystems, Sunnyvale, CA, USA; Zenith LP®, Cook Medical, Bloomington, IN, USA). As reports on anatomical suitability for EVAR are inconsistent, varying between 25 and 66%8–14 and most often referring to the most liberal anatomical restrictions for each device, we assessed the suitability of three commercially available EVAR devices according to the most conservative IFU definitions and explored the benefits of smaller diameter delivery systems on suitability. Our results demonstrate that even with continuous progress in stent graft design, majority of patients are still unsuitable for EVAR. Suitability is highest for Endurant® (48%) which is the newest device included in this study (US Food and Drug Administration approval in December 2010). This is achieved by smaller diameter delivery system and by accepting more hostile neck morphology and wider iliac attachment zones than the other two models. It is important to emphasize that not only outer diameter but even mechanical properties (flexibility, hydrophilic coating, etc.) are of great importance affecting not only advancement into the aorta but also the rotational movement needed for accurate deployment of the graft. Preoperative or intraoperative adjunctive maneuvers (i.e. angioplasty or the use of internal and external conduits) can also increase the number of patients treated without compromising the durability of the repair. Reducing diameters of delivery systems will increase overall suitability of EVAR devices by 10% at the most if no other factors in stent graft design are modified. This relates to the fact that non-suitability depends in equal amount on aneurysm neck characteristics excluding patients from infrarenal repair. In order to offer patients with hostile neck anatomy the positive benefits of EVAR, more complex devices are now available that allow for the sealing zone of the graft to be moved more proximal, either to the level of the visceral arteries or even further to the supracoeliac region. In these devices, the arterial blood flow to the vital organs is secured through fenestrations (fenestrated EVAR) or branches (branched EVAR), respectively. So far, those advanced systems require even larger delivery systems due to the more complicated graft design and the simultaneous need for multiple catheters and wires for successful deployment. When smaller deliver systems can also be applied to these more complex endografts, many of the anatomical restrictions inhibiting EVAR can be overcome.
Conclusion
Despite rapid device development during the past few years, most patients remain anatomically unsuitable for infrarenal EVAR according to the most conservative IFU definitions. Step-wise reduction in delivery system diameter can increase suitability by 10% at the most as hostile neck anatomy accounts for the remaining exclusion criteria.
